Page last updated: 2024-08-18

triethanolamine and Carcinoma, Ductal, Breast

triethanolamine has been researched along with Carcinoma, Ductal, Breast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andraos, T; Chehab, C; Eid, T; Geara, FB; Ramia, P; Thebian, R; Youssef, B; Zeidan, YH; Zouain, N1
Aistars, J; Vehlow, K1

Trials

1 trial(s) available for triethanolamine and Carcinoma, Ductal, Breast

ArticleYear
Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    American journal of clinical oncology, 2018, Volume: 41, Issue:12

    Topics: Administration, Topical; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Dermatologic Agents; Disease Management; Emulsions; Female; Follow-Up Studies; Humans; Lipids; Middle Aged; Prognosis; Prospective Studies; Radiodermatitis; Radiotherapy; Sitosterols

2018

Other Studies

1 other study(ies) available for triethanolamine and Carcinoma, Ductal, Breast

ArticleYear
Radiation dermatitis.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:8 Suppl

    Topics: Adult; Aloe; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Emulsions; Female; Follow-Up Studies; Humans; Lipids; Mastectomy, Segmental; Radiodermatitis; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome; Ultrasonography

2007